Table of Contents 1 NSAIDs Market Overview 1.1 Product Overview and Scope of NSAIDs 1.2 NSAIDs Segment by Type 1.2.1 Global NSAIDs Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Aspirin 1.2.3 Ibuprofen 1.2.4 Naproxen 1.2.5 Nabumetone 1.2.6 Others 1.3 NSAIDs Segment by Application 1.3.1 NSAIDs Sales Comparison by Application: 2020 VS 2026 1.3.2 Back Pain Treatment 1.3.3 Osteoarthritis Treatment 1.3.4 Other Disease Treatment 1.4 Global NSAIDs Market Size Estimates and Forecasts 1.4.1 Global NSAIDs Revenue 2015-2026 1.4.2 Global NSAIDs Sales 2015-2026 1.4.3 NSAIDs Market Size by Region: 2020 Versus 2026 2 Global NSAIDs Market Competition by Manufacturers 2.1 Global NSAIDs Sales Market Share by Manufacturers (2015-2020) 2.2 Global NSAIDs Revenue Share by Manufacturers (2015-2020) 2.3 Global NSAIDs Average Price by Manufacturers (2015-2020) 2.4 Manufacturers NSAIDs Manufacturing Sites, Area Served, Product Type 2.5 NSAIDs Market Competitive Situation and Trends 2.5.1 NSAIDs Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key NSAIDs Players (Opinion Leaders) 3 NSAIDs Retrospective Market Scenario by Region 3.1 Global NSAIDs Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global NSAIDs Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America NSAIDs Market Facts & Figures by Country 3.3.1 North America NSAIDs Sales by Country 3.3.2 North America NSAIDs Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe NSAIDs Market Facts & Figures by Country 3.4.1 Europe NSAIDs Sales by Country 3.4.2 Europe NSAIDs Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific NSAIDs Market Facts & Figures by Region 3.5.1 Asia Pacific NSAIDs Sales by Region 3.5.2 Asia Pacific NSAIDs Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America NSAIDs Market Facts & Figures by Country 3.6.1 Latin America NSAIDs Sales by Country 3.6.2 Latin America NSAIDs Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa NSAIDs Market Facts & Figures by Country 3.7.1 Middle East and Africa NSAIDs Sales by Country 3.7.2 Middle East and Africa NSAIDs Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global NSAIDs Historic Market Analysis by Type 4.1 Global NSAIDs Sales Market Share by Type (2015-2020) 4.2 Global NSAIDs Revenue Market Share by Type (2015-2020) 4.3 Global NSAIDs Price Market Share by Type (2015-2020) 4.4 Global NSAIDs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global NSAIDs Historic Market Analysis by Application 5.1 Global NSAIDs Sales Market Share by Application (2015-2020) 5.2 Global NSAIDs Revenue Market Share by Application (2015-2020) 5.3 Global NSAIDs Price by Application (2015-2020) 6 Company Profiles and Key Figures in NSAIDs Business 6.1 Bayer 6.1.1 Corporation Information 6.1.2 Bayer Description, Business Overview and Total Revenue 6.1.3 Bayer NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Bayer Products Offered 6.1.5 Bayer Recent Development 6.2 Novacap 6.2.1 Novacap NSAIDs Production Sites and Area Served 6.2.2 Novacap Description, Business Overview and Total Revenue 6.2.3 Novacap NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Novacap Products Offered 6.2.5 Novacap Recent Development 6.3 Abbott 6.3.1 Abbott NSAIDs Production Sites and Area Served 6.3.2 Abbott Description, Business Overview and Total Revenue 6.3.3 Abbott NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Abbott Products Offered 6.3.5 Abbott Recent Development 6.4 Pfizer 6.4.1 Pfizer NSAIDs Production Sites and Area Served 6.4.2 Pfizer Description, Business Overview and Total Revenue 6.4.3 Pfizer NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Pfizer Products Offered 6.4.5 Pfizer Recent Development 6.5 Johnson & Johnson 6.5.1 Johnson & Johnson NSAIDs Production Sites and Area Served 6.5.2 Johnson & Johnson Description, Business Overview and Total Revenue 6.5.3 Johnson & Johnson NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Johnson & Johnson Products Offered 6.5.5 Johnson & Johnson Recent Development 6.6 Cigna 6.6.1 Cigna NSAIDs Production Sites and Area Served 6.6.2 Cigna Description, Business Overview and Total Revenue 6.6.3 Cigna NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Cigna Products Offered 6.6.5 Cigna Recent Development 6.7 Geri-Care Pharmaceuticals 6.6.1 Geri-Care Pharmaceuticals NSAIDs Production Sites and Area Served 6.6.2 Geri-Care Pharmaceuticals Description, Business Overview and Total Revenue 6.6.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Geri-Care Pharmaceuticals Products Offered 6.7.5 Geri-Care Pharmaceuticals Recent Development 6.8 Perrigo Company 6.8.1 Perrigo Company NSAIDs Production Sites and Area Served 6.8.2 Perrigo Company Description, Business Overview and Total Revenue 6.8.3 Perrigo Company NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Perrigo Company Products Offered 6.8.5 Perrigo Company Recent Development 6.9 Kopran 6.9.1 Kopran NSAIDs Production Sites and Area Served 6.9.2 Kopran Description, Business Overview and Total Revenue 6.9.3 Kopran NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Kopran Products Offered 6.9.5 Kopran Recent Development 6.10 Merck Sharp & Dohme 6.10.1 Merck Sharp & Dohme NSAIDs Production Sites and Area Served 6.10.2 Merck Sharp & Dohme Description, Business Overview and Total Revenue 6.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Merck Sharp & Dohme Products Offered 6.10.5 Merck Sharp & Dohme Recent Development 6.11 Sun Pharmaceutical Industries 6.11.1 Sun Pharmaceutical Industries NSAIDs Production Sites and Area Served 6.11.2 Sun Pharmaceutical Industries NSAIDs Description, Business Overview and Total Revenue 6.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Sun Pharmaceutical Industries Products Offered 6.11.5 Sun Pharmaceutical Industries Recent Development 6.12 GlaxoSmithKline 6.12.1 GlaxoSmithKline NSAIDs Production Sites and Area Served 6.12.2 GlaxoSmithKline NSAIDs Description, Business Overview and Total Revenue 6.12.3 GlaxoSmithKline NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.12.4 GlaxoSmithKline Products Offered 6.12.5 GlaxoSmithKline Recent Development 6.13 Reddy Pharmaceuticals 6.13.1 Reddy Pharmaceuticals NSAIDs Production Sites and Area Served 6.13.2 Reddy Pharmaceuticals NSAIDs Description, Business Overview and Total Revenue 6.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Reddy Pharmaceuticals Products Offered 6.13.5 Reddy Pharmaceuticals Recent Development 6.14 Verywell 6.14.1 Verywell NSAIDs Production Sites and Area Served 6.14.2 Verywell NSAIDs Description, Business Overview and Total Revenue 6.14.3 Verywell NSAIDs Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Verywell Products Offered 6.14.5 Verywell Recent Development 7 NSAIDs Manufacturing Cost Analysis 7.1 NSAIDs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of NSAIDs 7.4 NSAIDs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 NSAIDs Distributors List 8.3 NSAIDs Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global NSAIDs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of NSAIDs by Type (2021-2026) 10.1.2 Global Forecasted Revenue of NSAIDs by Type (2021-2026) 10.2 NSAIDs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of NSAIDs by Application (2021-2026) 10.2.2 Global Forecasted Revenue of NSAIDs by Application (2021-2026) 10.3 NSAIDs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of NSAIDs by Region (2021-2026) 10.3.2 Global Forecasted Revenue of NSAIDs by Region (2021-2026) 10.4 North America NSAIDs Estimates and Projections (2021-2026) 10.5 Europe NSAIDs Estimates and Projections (2021-2026) 10.6 Asia Pacific NSAIDs Estimates and Projections (2021-2026) 10.7 Latin America NSAIDs Estimates and Projections (2021-2026) 10.8 Middle East and Africa NSAIDs Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global NSAIDs Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global NSAIDs Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global NSAIDs Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key NSAIDs Manufacturers Covered in This Study Table 5. Global NSAIDs Sales (K MT) by Manufacturers (2015-2020) Table 6. Global NSAIDs Sales Share by Manufacturers (2015-2020) Table 7. Global NSAIDs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global NSAIDs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market NSAIDs Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers NSAIDs Sales Sites and Area Served Table 11. Manufacturers NSAIDs Product Types Table 12. Global NSAIDs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global NSAIDs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAIDs as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key NSAIDs Players Table 16. Global NSAIDs Sales (K MT) by Region (2015-2020) Table 17. Global NSAIDs Sales Market Share by Region (2015-2020) Table 18. Global NSAIDs Revenue (Million US$) by Region (2015-2020) Table 19. Global NSAIDs Revenue Market Share by Region (2015-2020) Table 20. North America NSAIDs Sales by Country (2015-2020) (K MT) Table 21. North America NSAIDs Sales Market Share by Country (2015-2020) Table 22. North America NSAIDs Revenue by Country (2015-2020) (US$ Million) Table 23. North America NSAIDs Revenue Market Share by Country (2015-2020) Table 24. Europe NSAIDs Sales by Country (2015-2020) (K MT) Table 25. Europe NSAIDs Sales Market Share by Country (2015-2020) Table 26. Europe NSAIDs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe NSAIDs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific NSAIDs Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific NSAIDs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific NSAIDs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific NSAIDs Revenue Market Share by Region (2015-2020) Table 32. Latin America NSAIDs Sales by Country (2015-2020) (K MT) Table 33. Latin America NSAIDs Sales Market Share by Country (2015-2020) Table 34. Latin America NSAIDs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America NSAIDs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa NSAIDs Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa NSAIDs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa NSAIDs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa NSAIDs Revenue Market Share by Country (2015-2020) Table 40. Global NSAIDs Sales (K MT) by Type (2015-2020) Table 41. Global NSAIDs Sales Share by Type (2015-2020) Table 42. Global NSAIDs Revenue (Million US$) by Type (2015-2020) Table 43. Global NSAIDs Revenue Share by Type (2015-2020) Table 44. Global NSAIDs Price (USD/MT) by Type (2015-2020) Table 45. Global NSAIDs Sales (K MT) by Application (2015-2020) Table 46. Global NSAIDs Sales Market Share by Application (2015-2020) Table 47. Global NSAIDs Sales Growth Rate by Application (2015-2020) Table 48. Bayer NSAIDs Corporation Information Table 49. Bayer Description and Business Overview Table 50. Bayer NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Bayer Main Product Table 52. Bayer Recent Development Table 53. Novacap NSAIDs Corporation Information Table 54. Novacap Corporation Information Table 55. Novacap NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Novacap Main Product Table 57. Novacap Recent Development Table 58. Abbott NSAIDs Corporation Information Table 59. Abbott Corporation Information Table 60. Abbott NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Abbott Main Product Table 62. Abbott Recent Development Table 63. Pfizer NSAIDs Corporation Information Table 64. Pfizer Corporation Information Table 65. Pfizer NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Pfizer Main Product Table 67. Pfizer Recent Development Table 68. Johnson & Johnson NSAIDs Corporation Information Table 69. Johnson & Johnson Corporation Information Table 70. Johnson & Johnson NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Johnson & Johnson Main Product Table 72. Johnson & Johnson Recent Development Table 73. Cigna NSAIDs Corporation Information Table 74. Cigna Corporation Information Table 75. Cigna NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Cigna Main Product Table 77. Cigna Recent Development Table 78. Geri-Care Pharmaceuticals NSAIDs Corporation Information Table 79. Geri-Care Pharmaceuticals Corporation Information Table 80. Geri-Care Pharmaceuticals NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Geri-Care Pharmaceuticals Main Product Table 82. Geri-Care Pharmaceuticals Recent Development Table 83. Perrigo Company NSAIDs Corporation Information Table 84. Perrigo Company Corporation Information Table 85. Perrigo Company NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Perrigo Company Main Product Table 87. Perrigo Company Recent Development Table 88. Kopran NSAIDs Corporation Information Table 89. Kopran Corporation Information Table 90. Kopran NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Kopran Main Product Table 92. Kopran Recent Development Table 93. Merck Sharp & Dohme NSAIDs Corporation Information Table 94. Merck Sharp & Dohme Corporation Information Table 95. Merck Sharp & Dohme NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Merck Sharp & Dohme Main Product Table 97. Merck Sharp & Dohme Recent Development Table 98. Sun Pharmaceutical Industries NSAIDs Corporation Information Table 99. Sun Pharmaceutical Industries Corporation Information Table 100. Sun Pharmaceutical Industries NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 101. Sun Pharmaceutical Industries Main Product Table 102. Sun Pharmaceutical Industries Recent Development Table 103. GlaxoSmithKline NSAIDs Corporation Information Table 104. GlaxoSmithKline Corporation Information Table 105. GlaxoSmithKline NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 106. GlaxoSmithKline Main Product Table 107. GlaxoSmithKline Recent Development Table 108. Reddy Pharmaceuticals NSAIDs Corporation Information Table 109. Reddy Pharmaceuticals Corporation Information Table 110. Reddy Pharmaceuticals NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 111. Reddy Pharmaceuticals Main Product Table 112. Reddy Pharmaceuticals Recent Development Table 113. Verywell NSAIDs Corporation Information Table 114. Verywell Corporation Information Table 115. Verywell NSAIDs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 116. Verywell Main Product Table 117. Verywell Recent Development Table 118. Sales Base and Market Concentration Rate of Raw Material Table 119. Key Suppliers of Raw Materials Table 120. NSAIDs Distributors List Table 121. NSAIDs Customers List Table 122. Market Key Trends Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 124. Key Challenges Table 125. Global NSAIDs Sales (K MT) Forecast by Type (2021-2026) Table 126. Global NSAIDs Sales Market Share Forecast by Type (2021-2026) Table 127. Global NSAIDs Revenue (Million US$) Forecast by Type (2021-2026) Table 128. Global NSAIDs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 129. Global NSAIDs Sales (K MT) Forecast by Application (2021-2026) Table 130. Global NSAIDs Revenue (Million US$) Forecast by Application (2021-2026) Table 131. Global NSAIDs Sales (K MT) Forecast by Region (2021-2026) Table 132. Global NSAIDs Sales Market Share Forecast by Region (2021-2026) Table 133. Global NSAIDs Revenue Forecast by Region (2021-2026) (US$ Million) Table 134. Global NSAIDs Revenue Market Share Forecast by Region (2021-2026) Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Picture of NSAIDs Figure 2. Global NSAIDs Sales Market Share by Type: 2020 VS 2026 Figure 3. Aspirin Product Picture Figure 4. Ibuprofen Product Picture Figure 5. Naproxen Product Picture Figure 6. Nabumetone Product Picture Figure 7. Others Product Picture Figure 8. Global NSAIDs Consumption Market Share by Application: 2020 VS 2026 Figure 9. Back Pain Treatment Figure 10. Osteoarthritis Treatment Figure 11. Other Disease Treatment Figure 12. Global NSAIDs Market Size 2015-2026 (US$ Million) Figure 13. Global NSAIDs Sales Capacity (K MT) (2015-2026) Figure 14. Global NSAIDs Market Size Market Share by Region: 2020 Versus 2026 Figure 15. NSAIDs Sales Share by Manufacturers in 2020 Figure 16. Global NSAIDs Revenue Share by Manufacturers in 2019 Figure 17. The Global 5 and 10 Largest Players: Market Share by NSAIDs Revenue in 2019 Figure 18. NSAIDs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global NSAIDs Sales Market Share by Region (2015-2020) Figure 20. Global NSAIDs Sales Market Share by Region in 2019 Figure 21. Global NSAIDs Revenue Market Share by Region (2015-2020) Figure 22. Global NSAIDs Revenue Market Share by Region in 2019 Figure 23. North America NSAIDs Sales Market Share by Country in 2019 Figure 24. North America NSAIDs Revenue Market Share by Country in 2019 Figure 25. U.S. NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 26. U.S. NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Canada NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 28. Canada NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Europe NSAIDs Sales Market Share by Country in 2019 Figure 30. Europe NSAIDs Revenue Market Share by Country in 2019 Figure 31. Germany NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 32. Germany NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. France NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 34. France NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. U.K. NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 36. U.K. NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Italy NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 38. Italy NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Russia NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 40. Russia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Asia Pacific NSAIDs Sales Market Share by Region in 2019 Figure 42. Asia Pacific NSAIDs Revenue Market Share by Region in 2019 Figure 43. China NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 44. China NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Japan NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 46. Japan NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. South Korea NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 48. South Korea NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. India NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 50. India NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Australia NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 52. Australia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Taiwan NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 54. Taiwan NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Indonesia NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 56. Indonesia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Thailand NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 58. Thailand NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Malaysia NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 60. Malaysia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Philippines NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 62. Philippines NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Vietnam NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 64. Vietnam NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Latin America NSAIDs Sales Market Share by Country in 2019 Figure 66. Latin America NSAIDs Revenue Market Share by Country in 2019 Figure 67. Mexico NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 68. Mexico NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Brazil NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 70. Brazil NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Argentina NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 72. Argentina NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Middle East and Africa NSAIDs Sales Market Share by Country in 2019 Figure 74. Middle East and Africa NSAIDs Revenue Market Share by Country in 2019 Figure 75. Turkey NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 76. Turkey NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Saudi Arabia NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 78. Saudi Arabia NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. U.A.E NSAIDs Sales Growth Rate (2015-2020) (K MT) Figure 80. U.A.E NSAIDs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Sales Market Share of NSAIDs by Type (2015-2020) Figure 82. Sales Market Share of NSAIDs by Type in 2019 Figure 83. Revenue Share of NSAIDs by Type (2015-2020) Figure 84. Revenue Market Share of NSAIDs by Type in 2019 Figure 85. Global NSAIDs Sales Growth by Type (2015-2020) (K MT) Figure 86. Global NSAIDs Sales Market Share by Application (2015-2020) Figure 87. Global NSAIDs Sales Market Share by Application in 2019 Figure 88. Global Revenue Share of NSAIDs by Application (2015-2020) Figure 89. Global Revenue Share of NSAIDs by Application in 2020 Figure 90. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Novacap Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Cigna Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Geri-Care Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Perrigo Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Kopran Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Merck Sharp & Dohme Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Reddy Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Verywell Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Price Trend of Key Raw Materials Figure 105. Manufacturing Cost Structure of NSAIDs Figure 106. Manufacturing Process Analysis of NSAIDs Figure 107. NSAIDs Industrial Chain Analysis Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Porter's Five Forces Analysis Figure 111. North America NSAIDs Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 112. North America NSAIDs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Europe NSAIDs Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 114. Europe NSAIDs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Latin America NSAIDs Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 116. Latin America NSAIDs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Middle East and Africa NSAIDs Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 118. Middle East and Africa NSAIDs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 119. Asia Pacific NSAIDs Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 120. Asia Pacific NSAIDs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 121. Bottom-up and Top-down Approaches for This Report Figure 122. Data Triangulation Figure 123. Key Executives Interviewed

Bayer Novacap Abbott Pfizer Johnson & Johnson Cigna Geri-Care Pharmaceuticals Perrigo Company Kopran Merck Sharp & Dohme Sun Pharmaceutical Industries GlaxoSmithKline Reddy Pharmaceuticals Verywell